Hanmi Pharm Co. passed the 100 billion won mark in R&D investment for the first time among pharmaceu
(Yakup Shinmoon)
Hanmi Pharm Co. announced that they passed the 100 billion won mark in R&D investment for the first time among pharmaceutical companies listed o...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
